VANCOUVER, March 4, 2013 /PRNewswire/ - Biocell Labs Inc., a
wholly owned subsidiary of Abattis Bioceuticals Corp. (the
"Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces
the engagement of Dr. Paula Brown to
provide the Company with the expertise and assistance needed to
expand its capacity into the production of novel bio-pharmaceutical
products.
Mr. Mike Withrow, Chief Executive
Officer on behalf of the Company, stated, "we are very pleased to
have Dr. Brown join the Board of Biocell Labs Inc. with her
extensive knowledge, the Company continues to deliver on its plan
to become a fully integrated bioceutical company that offers
cutting-edge proprietary products to the medicinal, nutraceutical
and cosmetic industries."
Paula N. Brown, Ph.D., Director
of Applied Research for BCIT's Natural Health & Food Products
Research Group stated, "I am very excited about this opportunity to
work with Biocell Labs Inc. to advance their integrated model,
employing vertical automated growing systems and novel extraction
technologies, to develop health and wellness products derived from
medicinal plants." As far back as 2001 inconsistencies in raw
materials, poor product quality and the absence of validated
analytical methods have been identified as a public health risk and
barrier to rigorous scientific study. Dr. Brown went on to state,
"my research has grown out of a desire to apply scientific
principles and advanced chemoanalytical tools to ensure consumers
have confidence in the products they are ingesting."
Abattis Bioceutical Corporation would also like to announce that
it has acquired from Dr. Brown a portfolio of natural health
product formulas focusing on pain management, immunity &
inflammation and cognitive function in exchange for 400,000 shares
of Abattis.
The Biography of Dr. Paula
Brown
Dr. Paula Brown, as Director of
the BC Institute of Technology's Natural Health and Food Products
Research Group, has been actively supporting the NHP industry for
over a decade through applied research activities including product
development, establishment of quality standards and regulatory
compliance. By providing fundamental investigations on product
quality, safety and efficacy, BCIT supports industry through the
entire continuum, from grower to manufacturer, ensuring product
integrity is maintained. Dr. Brown has spoken at numerous
conferences over the last decade on product quality standards,
analytical method validation and is currently Chair of NSF's
Dietary Supplement Joint Committee. Dr. Brown sits on the advisory
Board of the American Botanical Council, is a Fellow of the AOAC
International having served as General Referee for the Dietary
Supplement Methods Committee from 2004-2009, from 2008-2013 was
"Quality Focus" columnist for Nutraceuticals World, an Industry
Trade Journal published by Rodman Publishing. Dr. Brown has
reviewed and contributed to several American Herbal Pharmacopeia
Monographs including Black Cohosh and Ginseng.
About Abattis Bioceuticals Corp.
Abattis Bioceuticals Corp. is a specialty biotechnology company
with capabilities through its wholly owned subsidiaries of
producing, licensing and marketing proprietary ingredients and
products containing standardized phytochemicals for sale in
Pharmaceutical, Nutraceutical, Cosmetic and Animal Nutrition
markets. The company also has a deep pipeline of proprietary
products ready for sale in high growth areas of Functional Foods
and Supplements business. For more information, visit the Company's
website at www.abattis.com.
ON BEHALF OF THE BOARD
"Michael Withrow"
___________________________
Michael Withrow, President &
CEO
Neither the CNSX Exchange nor its regulations
services accepts responsibility
for the adequacy or accuracy of this release.
SOURCE Abattis Bioceuticals Corp.
